المؤلفون: Ivan Krečak, Sandra Bašić-Kinda, Dino Dujmović, Ida Hude, Ivo Radman-Livaja, Klara Dubravčić, Koraljka Gjadrov Kuveždić, Ivana Ilić, Igor Aurer

المصدر: Liječnički vjesnik
Volume 139
Issue 7-8

مصطلحات موضوعية: Kronična limfocitna leukemija – farmakoterapija, komplikacije, Vidarabin – analozi i derivati, način uporabe i doziranje, nuspojave, terapijska primjena, Ciklofosfamid – način uporabe i doziranje, nuspojave, terapijska primjena, Rituksimab – način uporabe i doziranje, nuspojave, terapijska primjena, Protutumorski lijekovi – način uporabe i doziranje, nuspojave, terapijska primjena, Kombinirani protutumorski kemoterapijski protokoli – način uporabe i doziranje, nuspojave, terapijska primjena, Ishod liječenja, Indukcija remisije, Preživljenje bez progresije bolesti, Leukemia, lymphocytic, chronic, B-cell – complications, drug therapy, Vidarabine – administration and dosage, adverse effects, analogs and derivatives, therapeutic use, Cyclophosphamide – administration and dosage, adverse effects, therapeutic use, Rituximab – administration and dosage, adverse effects, therapeutic use, Antineoplastic agents – administration and dosage, adverse effects, therapeutic use, Antineoplastic combined chemotherapy protocols – administration and dosage, adverse effects, therapeutic use, Treatment outcome, Remission induction, Disease-free survival

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______951::c62dbe25d4222123aeb21cb0c234d784
https://hrcak.srce.hr/file/279527